ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Net Debt history
Currency unavailable · from the balance sheet
No Net Debt data reported for this period type.
Net Debt vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $50.41M USD | +72.2% | — | 17.1% | |
| Mar 2026 | $15.99M USD | +11.4% | — | 6.5% | |
| Mar 2026 | -$5.52M USD | +91.5% | — | 4.8% | |
| Mar 2026 | -€67.47M EUR | +46.8% | — | 68.1% | |
| Mar 2026 | -$152.24M USD | +44.1% | — | 34.3% | |
| Mar 2026 | -$183.89M USD | -79.2% | — | 98.3% | |
| Mar 2026 | -$187.39M USD | -7.5% | — | 76.4% | |
| Mar 2026 | -$265.17M USD | — | — | 90.7% | |
| Mar 2026 | -$528.88M USD | -141.0% | — | 90.6% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +27.8% | — | 68.1% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.